Case Reports
3 August 2017
Vol. 69 No. 2 (2017)
https://doi.org/10.4081/reumatismo.2017.923

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Myelodisplastic syndrome, Myositis specific autoantibodies, Anti-TIF1γ, Dermatomyositis.
1510
Views
843
Downloads

Authors

B. Palterer
Experimental and Clinical Medicine Dept., University of Florence, Florence, Italy.
G. Vitiello
gianfranco.vitiello@unifi.it
Experimental and Clinical Medicine Dept., University of Florence, Florence, Italy.
D. Cammelli
Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence, Italy.
Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

-
B. Palterer, Experimental and Clinical Medicine Dept., University of Florence, Florence
Resident in Allergy and Clinical Immunology
G. Vitiello, Experimental and Clinical Medicine Dept., University of Florence, Florence
Resident in Allergy and Clinical Immunology
D. Cammelli, Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence
Head of the Reumatology Section of the Immunoallergology Unit

How to Cite



First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome. (2017). Reumatismo, 69(2), 75-77. https://doi.org/10.4081/reumatismo.2017.923

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.